3-甲氧基-5-甲基苯胺 | 66584-31-4

• 物质功能分类: 有机原料 - 氨基化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 3-甲氧基-5-甲基苯胺
• 中文别名: 3-甲氧基-5-甲基-苯胺
• 英文名称: 3-methoxy-5-methylaniline
• CAS: 66584-31-4
• 化学式: C₈H₁₁NO
• 分子量: 137.181
• InChiKey: SIYIMMXOEYEZHK-UHFFFAOYSA-N

物化性质

• 熔点：
  46-47 °C
• 沸点：
  150-152 °C(Press: 22 Torr)
• 密度：
  1.039±0.06 g/cm3(Predicted)
• 溶解度：
  氯仿（微溶）、乙酸乙酯（微溶）

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2922299090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-Methoxy-5-methylphenylamine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-Methoxy-5-methylphenylamine
CAS number: 66584-31-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H11NO
Molecular weight: 137.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-甲氧基-5-甲基苯胺 在 盐酸 、 正丁基锂 、 氯化亚砜 、 四甲基乙二胺 、 硫酸 、 二苯基膦酰羟胺 、 sodium hydride 、 对甲苯磺酸 、 三乙胺 作用下， 以 四氢呋喃 、 甲醇 、 乙二醇二甲醚 、 正己烷 、 二氯甲烷 、 水 为溶剂， 反应 44.25h， 生成 methyl 1-(4-bromobutyl)-4-methoxy-6-methyl-1H-indazole-3-carboxylate
  参考文献：
  名称：

  Total Synthesis of Nigellicine and Nigeglanine Hydrobromide

  摘要：

  [GRAPHICS]The first syntheses of the pyridazinoindazolium alkaloids nigellicine and nigeglanine hydrobromide via a common intermediate are described. Ortho-lithiation/acylation and the direct amination of an isatin ring system are the key steps in the synthesis.

  DOI：

  10.1021/ol050769m
• 作为产物：
  描述：

  3,5-二硝基甲苯 在 盐酸 、 ammonium polysulphide 、 tin(ll) chloride 作用下， 以 甲醇 为溶剂， 反应 10.0h， 生成 3-甲氧基-5-甲基苯胺
  参考文献：
  名称：

  氯化吡咯与一些取代的苯胺反应的动力学。第5部分

  摘要：

  已测量了氯化吡咯与以下取代的苯胺在乙腈中的反应的Arrhenius参数：3-氨基和3-甲基苯胺，3-氨基-5-硝基苯胺，3-氟-5-甲基磺酰基苯胺，3- X-5-甲基苯胺（X = NO 2，OMe，CH 3，F，Cl，Br或I）和3,5-X 2-苯胺（X = F，Cl，Br或I）。现已研究了总共33个3,5-二取代苯胺对取代基对活化自由能的可加性的影响，并且表明，除3-氨基-5-硝基苯胺外，该假说重现了实验速率常数。在2分之一的范围内，当使用更严格的可加性标准时，对于某些情况下出现的偏差提出了合理化建议。

  DOI：

  10.1039/p29800000829

文献信息

• [EN] AZIRIDINE SPINOSYN DERIVATIVES AND METHODS OF MAKING<br/>[FR] DÉRIVÉS D'AZIRIDINE SPINOSYNE ET LEURS PROCÉDÉS DE FABRICATION
  申请人：AGRIMETIS LLC

  公开号：WO2018132288A1

  公开（公告）日：2018-07-19

  Compositions including derivatives of spinosyns of the following formulae and methods for the production of derivatives of spinosyns are provided. The spinosyn derivatives described herein include those functionalized on the C-5,6 double bond to provide an aziridine ring system. The method produces spinosyn derivatives that exhibit activity towards insects, arachnids, and nematodes and are useful in the agricultural and animal health markets.

  提供了包括以下公式的自旋菌素衍生物的组合物，以及用于生产自旋菌素衍生物的方法。本文描述的自旋菌素衍生物包括在C-5,6双键上官能化以提供环氮丙烷环系统的衍生物。该方法生产出对昆虫、蜘蛛和线虫具有活性的自旋菌素衍生物，并在农业和动物健康市场中有用。
• Synthesis of Indole-Fused Polycyclics via Rhodium-Catalyzed Undirected C–H Activation/Alkene Insertion
  作者：Songjin Guo、Rui Pan、Zhe Guan、Panpan Li、Libo Cai、Siwei Chen、Aijun Lin、Hequan Yao

  DOI：10.1021/acs.orglett.9b02198

  日期：2019.8.16

  Rh(III)-catalyzed undirected C–H activation/alkene insertion to synthesize diversified indole-fused polycyclics has been developed. Intramolecular electrophilic cyclization generated a 3-indolyl rhodium species that went through an aryl-to-aryl 1,4-rhodium migration to realize the C–H activation. The subsequent [4 + 2] carboannulation or hydroarylation of alkenes could be achieved, respectively, by simply

  已经开发了一种Rh（III）催化的无向CH活化/烯烃插入物来合成多种吲哚稠合的多环化合物。分子内亲电环化反应生成了3-吲哚基铑物种，该物种经过芳基到芳基的1,4-铑迁移而实现了CH活化。通过简单地调节反应的添加剂，可以分别实现随后的烯烃的[4 + 2]碳环化或加氢芳基化。
• [EN] MACROCYCLIC SULFONYLUREA DERIVATIVES USEFUL AS NLRP3 INHIBITORS<br/>[FR] DÉRIVÉS DE SULFONYLURÉE MACROCYCLIQUES UTILES EN TANT QU'INHIBITEURS DE NLRP3
  申请人：INFLAZOME LTD

  公开号：WO2021032591A1

  公开（公告）日：2021-02-25

  The present invention relates to macrocyclic compounds, such as macrocyclic sulfonyl ureas. The present invention further relates to associated salts, solvates, prodrugs and pharmaceutical compositions and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by NLRP 3 inhibition.

  本发明涉及大环化合物，如大环磺酰脲。本发明还涉及相关的盐、溶剂合物、前药和药物组合物，以及利用这些化合物在治疗和预防医学障碍和疾病中的应用，尤其是通过NLRP 3抑制。
• AMINATION AND HYDROXYLATION OF ARYLMETAL COMPOUNDS
  申请人：WILLIAM MARSH RICE UNIVERSITY

  公开号：US20180057444A1

  公开（公告）日：2018-03-01

  In one aspect, the present disclosure provides methods of preparing a primary or secondary amine and hydroxylated aromatic compounds. In some embodiments, the aromatic compound may be unsubstituted, substituted, or contain one or more heteroatoms within the rings of the aromatic compound. The methods described herein may be carried out without the need for transition metal catalysts or harsh reaction conditions.

  在一个方面，本公开提供了制备初级或次级胺和含羟基芳香化合物的方法。在一些实施例中，芳香化合物可以是未取代的、取代的，或者在芳香化合物的环中含有一个或多个杂原子。本文描述的方法可以在不需要过渡金属催化剂或苛刻反应条件的情况下进行。
• FUSED PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROTIC DISEASES
  申请人：Galapagos N.V.

  公开号：EP3782997A1

  公开（公告）日：2021-02-24

  The present invention discloses compounds according to Formula I: Wherein A, B, R1, R2, and Cy are as defined herein. The present invention relates to compounds inhibiting autotaxin (NPP2 or ENPP2), methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of fibrotic diseases, proliferative diseases, inflammatory diseases, autoimmune diseases, respiratory diseases, cardiovascular diseases, neurodegenerative diseases, dermatological disorders, pain, and/or abnormal angiogenesis associated diseases by administering the compounds of the invention.

  本发明公开了根据式I的化合物：其中A、B、R1、R2和Cy如本文所定义。本发明涉及抑制自体脂肪酶（NPP2或ENPP2）的化合物，其生产方法，包含其的药物组合物，以及使用该化合物进行预防和/或治疗纤维化疾病、增生性疾病、炎症性疾病、自身免疫疾病、呼吸系统疾病、心血管疾病、神经退行性疾病、皮肤疾病、疼痛和/或异常血管生成相关疾病的方法。